Latest News & Updates

Breaking News

  • 4 hours ago

  • Pharma Now Editorial Team

Glenmark Pharma Launches Vancomycin Injection in U.S. Following Bioequivalence Clearance Against Fresenius Kabi Reference
Breaking News
Boehringer Ingelheim Gains Japan MHLW Approval for Nerandomilast in IPF and PPF

Pharma Now Editorial Team

Other trending news you may like to read

Glenmark Pharma Launches Vancomycin Injection in U.S. Following Bioequivalence Clearance Against Fresenius Kabi Reference

Glenmark Pharma enters U.S. injectable generics with Vancomycin, bioequivalent to Fresenius Kabi's reference listed drug.

Pharma Now Editorial Team

Pharma Now

Boehringer Ingelheim Gains Japan MHLW Approval for Nerandomilast in IPF and PPF

Japan's MHLW approves nerandomilast for IPF and PPF, making Japan the fourth market to clear Boehringer Ingelheim's PDE4B inhibitor.

Pharma Now Editorial Team

Pharma Now

Solara Active Pharma Secures FY26 Revenue Recovery but Ibuprofen Unit Posts Negative EBITDA

Solara's ibuprofen unit posted negative EBITDA of Rs. 179M in Q4 despite 61% revenue growth, triggering a formal strategic review.

Pharma Now Editorial Team

Pharma Now

Gland Pharma Posts Record Q4 FY26 Revenue as CDMO Injectable Demand Accelerates

Gland Pharma reports record Q4 FY26 revenue and near-doubled profit, with a 38% adjusted EBITDA margin driven by CDMO injectable segment growth.

Pharma Now Editorial Team

Pharma Now